David J. Taylor
David J. Taylor (R-OH) sold $1K-$15K of $AMGN (Amgen Inc. - Common Stock) on Dec 3, 2025, part of 3 transactions in this filing (1 buys, 2 sells).
HillSignal flagged 5 timing concerns on this filing — trades that line up closely with related legislative or contract activity.
Price Movement Since Trade
How the largest positions have moved from the trade date to the most recent close.
Suspicious Timing Detected
5 flagsRep. Taylor bought $1,001 - $15,000 in $V (Visa Inc.) on 2025-12-03, 1 day before the HUSTLE Act (S3378) was introduced, which proposes tax-exempt NIL investment accounts that could expand the market for financial services.
Rep. Taylor sold $1,001 - $15,000 in $AMGN (Amgen Inc. - Common Stock) on 2025-12-03, 2 days before the 'Skinny Labels, Big Savings Act' (HR6485) was introduced, aiming to reduce patent infringement risk for generic drug manufacturers.
Rep. Taylor sold $1,001 - $15,000 in $AMGN (Amgen Inc. - Common Stock) on 2025-12-03, 69 days before the 'Break Up Big Medicine Act' (S3822) was introduced, which aims to prohibit common ownership between pharmaceutical companies.
Rep. Taylor bought $1,001 - $15,000 in $V (Visa Inc.) on 2025-12-03, 70 days before the Financial Stability Oversight Council Improvement Act of 2025 was introduced, which could impact financial institutions.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Financial Stability Oversight Council Improvement Act of 2025
HR 3682 (Financial Stability Oversight Council Improvement Act) passed the House 2026-02-09 and now has an identical Senate companion bill (S3578). The bill requires FSOC to exhaust alternative actions before designating nonbank financial firms as systemically important, reducing regulatory risk for large nonbank financial companies. This is structurally bullish for Berkshire Hathaway, Blackstone, PayPal, Visa, and Mastercard by lowering odds of future Fed supervision and associated capital requirements.
GAP Supply Act
The GAP Supply Act (HR7528) is an early-stage procedural bill with no funding authorization. It extends a regulatory timeline for compounding facilities during drug shortages but has near-zero near-term market impact. Current real market data shows $VTRS at $15.04 within its 52-week range of $8.19–$16.47, with a +11.32% 30-day gain reflecting broader market trends, not this bill.
Break Up Big Medicine Act
The Break Up Big Medicine Act (S.3822) targets the vertical integration of healthcare giants by prohibiting common ownership of PBMs, insurers, and drug wholesalers. In early committee stage with bipartisan sponsorship, the bill poses a structural risk to UnitedHealth Group's business model while potentially easing pricing pressure on pharmaceutical manufacturers like Pfizer.
Combatting Money Laundering in Cyber Crime Act of 2025
HR5877 expands Secret Service authority over digital-asset money laundering and extends FinCEN reporting mandates, increasing compliance burdens for digital asset companies. Pure-play crypto firms ($COIN, $RIOT, $MARA, $BKKT) face higher regulatory risk and costs, while diversified fintech ($PYPL) absorbs impact more easily. Digital asset stocks show 30-day gains but sharp 7-day declines, suggesting market is already pricing in regulatory headwinds.
Skinny Labels, Big Savings Act
HR6485 (Skinny Labels, Big Savings Act) creates a statutory safe harbor protecting generic and biosimilar manufacturers from patent infringement liability when marketing drugs for non-patented indications, directly reversing the GlaxoSmithKline v. Teva precedent. Generic makers TEVA and VTRS are structural winners, with reduced litigation risk supporting their generic launch strategies. Brand-name manufacturers AMGN, PFE, JNJ, and MRK face accelerated competitive erosion on their top-selling drugs. The bill is early-stage (referred to House Judiciary), but companion Senate bill S43 signals bipartisan interest.
Pensions for All Act
HR7556 mandates employer-provided retirement plans, structurally bullish for asset managers like BlackRock ($BLK) by expanding AUM. However, the bill is in early stage, referred to three committees in February 2026, with no clear path to passage. Market impact is limited to long-term structural narrative; no near-term catalyst.
Bringing the Discount Window into the 21st Century Act
HR3390 is a procedural bill requiring a Federal Reserve review of discount window operations. It authorizes no funding, mandates no contracts, and has zero material linkage to any publicly traded company's revenue or costs. No actionable market impact exists for retail investors.
PROTECT Taiwan Act
HR1531 (PROTECT Taiwan Act) is an early-stage bill that authorizes no spending and creates only contingent geopolitical risk for major U.S. banks with Asia exposure. Real market data shows C, BAC, and MS are all trading near their 52-week highs with positive momentum over the last 30 days. No immediate market impact; the bill remains in committee.
HUSTLE Act
The HUSTLE Act (S.3378) is an early-stage bill introduced in December 2025 proposing tax-exempt NIL investment accounts for student-athletes. It has been referred to the Senate Committee on Finance and has not advanced. The bill has no funding authorization and minimal near-term market impact. Financial services stocks like $SCHW and $PYPL show mixed performance over the past 7 days, with no correlation to this legislation.
Community Bank Relief Act
HR7484 (Community Bank Relief Act) is an early-stage procedural bill that indexes payment card transaction fee thresholds to inflation. It formalizes existing economic adjustments without altering current fee structures, regulatory obligations, or revenue for any payment processor. Market data shows mixed performance across the payment sector unrelated to this legislation. No immediate market impact.
Other Filings by David J. Taylor
Free — no credit card
Get the next Taylor trade the day it's disclosed
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.